Opioid receptor genes inactivated in mice:: the highlights

被引:105
作者
Gavériaux-Ruff, C [1 ]
Kieffer, BL [1 ]
机构
[1] ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
关键词
D O I
10.1054/npep.2002.0900
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The opioid system controls nociception, stress responses, and addictive behaviors. Exogenous alkaloid opiates and endogenous opioid peptides stimulate mu-, delta- and kappa-opioid receptors, whose activities have long been analyzed by pharmacological tools. Mice lacking opioid receptor and opioid peptide precursor genes have now been produced by gene targeting. Behavioral analysis of mutant animals in the absence of drug has highlighted a distinct role of opioid receptors or peptides in nociception and revealed an important role for delta receptors in emotional behaviors. The examination of responses to drugs has clarified involvement of each receptor as molecular targets for exogenous opiates in vivo. Those data have also demonstrated the critical role of mu-receptor in cannabinoid and alcohol reinforcement and confirmed the involvement of kappa receptor in several dysphoric responses. Ongoing studies therefore help in understanding the molecular basis of opioid-controlled behaviors and will contribute to the development of novel therapeutics for pain, anxiety, and drug abuse. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:62 / 71
页数:10
相关论文
共 66 条
[1]   Molecular and neuroanatomical properties of the endogenous opioid system: Implications for treatment of opiate addiction [J].
Akil, H ;
Meng, F ;
Devine, DP ;
Watson, SJ .
SEMINARS IN NEUROSCIENCE, 1997, 9 (3-4) :70-83
[2]  
ARAKAWA K, 1993, TRANSPLANT P, V25, P738
[3]   ANTIDEPRESSANT-TYPE EFFECTS OF ENDOGENOUS ENKEPHALINS PROTECTED BY SYSTEMIC RB-101 ARE MEDIATED BY OPIOID-DELTA AND DOPAMINE-D1 RECEPTOR STIMULATION [J].
BAAMONDE, A ;
DAUGE, V ;
RUIZGAYO, M ;
FULGA, IG ;
TURCAUD, S ;
FOURNIEZALUSKI, MC ;
ROQUES, BP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 216 (02) :157-166
[4]   Morphine self-administration in μ-opioid receptor-deficient mice [J].
Becker, A ;
Grecksch, G ;
Brödemann, R ;
Kraus, J ;
Peters, B ;
Schroeder, H ;
Thiemann, V ;
Loh, HH ;
Höllt, V .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (06) :584-589
[5]   Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking [J].
Devi, LA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (10) :532-537
[6]   Selective δ opioid receptor agonists for inflammatory and neuropathic pain [J].
Dondio, G ;
Ronzoni, S ;
Farina, C ;
Graziani, D ;
Parini, C ;
Petrillo, P ;
Giardina, GAM .
FARMACO, 2001, 56 (1-2) :117-119
[7]   Mice deficient for δ- and γ-opioid receptors exhibit opposing alterations of emotional responses [J].
Filliol, D ;
Ghozland, S ;
Chluba, J ;
Martin, M ;
Matthes, HWD ;
Simonin, F ;
Befort, K ;
Gavériaux-Ruff, C ;
Dierich, A ;
LeMeur, M ;
Valverde, O ;
Maldonado, R ;
Kieffer, BL .
NATURE GENETICS, 2000, 25 (02) :195-200
[8]   Characterization of mechanical withdrawal responses and effects of μ-, δ- and κ-opioid agonists in normal and μ-opioid receptor knockout mice [J].
Fuchs, PN ;
Roza, C ;
Sora, I ;
Uhl, G ;
Raja, SN .
BRAIN RESEARCH, 1999, 821 (02) :480-486
[9]  
Gavériaux-Ruff C, 2001, J PHARMACOL EXP THER, V298, P1193
[10]  
GAVERIAUXRUFF C, 1999, OPIOIDS PAIN CONTROL, P1